|
|
Volumn 105, Issue 9, 2014, Pages 1142-1151
|
|
Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
(S) 4 (1 (5 CHLORO 2 (4 FLUOROPHENYOXY) BENZAMIDO)ETHYL) BENZOIC ACID;
(S)-4-(1-(5-CHLORO-2-(4-FLUOROPHENYOXY) BENZAMIDO)ETHYL) BENZOIC ACID;
ANTINEOPLASTIC AGENT;
BENZAMIDE DERIVATIVE;
CELECOXIB;
CYCLOOXYGENASE 2;
PROSTAGLANDIN E RECEPTOR 4;
PTGS2 PROTEIN, MOUSE;
PYRAZOLE DERIVATIVE;
SULFONAMIDE;
VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE;
VASCULOTROPIN A;
ADENOCARCINOMA;
ANIMAL;
APOPTOSIS;
ARTICLE;
C3H MOUSE;
CANCER STEM CELL;
CANCER TRANSPLANTATION;
CELL PROLIFERATION;
DRUG ANTAGONISM;
DRUG SCREENING;
EXPERIMENTAL MAMMARY NEOPLASM;
FEMALE;
LUNG TUMOR;
LYMPH NODE METASTASIS;
LYMPHANGIOGENESIS;
MACROPHAGE;
METABOLISM;
METASTASIS;
MOLECULARLY TARGETED THERAPY;
MOUSE;
NEOVASCULARIZATION (PATHOLOGY);
PATHOLOGY;
PROSTAGLANDIN E2 RECEPTOR EP4 SUBTYPE;
RQ-00015986;
TUMOR CELL LINE;
TUMOR VOLUME;
VASCULARIZATION;
CANCER STEM CELLS;
CYCLOOXYGENASE 2;
MACROPHAGES;
PROSTAGLANDIN E2 RECEPTOR EP4 SUBTYPE;
RQ-00015986;
ADENOCARCINOMA;
ANIMALS;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
BENZAMIDES;
CELL LINE, TUMOR;
CELL PROLIFERATION;
CYCLOOXYGENASE 2;
DRUG SCREENING ASSAYS, ANTITUMOR;
FEMALE;
LUNG NEOPLASMS;
LYMPHANGIOGENESIS;
LYMPHATIC METASTASIS;
MACROPHAGES;
MAMMARY NEOPLASMS, EXPERIMENTAL;
MICE;
MICE, INBRED C3H;
MOLECULAR TARGETED THERAPY;
NEOPLASM TRANSPLANTATION;
NEOPLASTIC STEM CELLS;
NEOVASCULARIZATION, PATHOLOGIC;
PYRAZOLES;
RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE;
SULFONAMIDES;
TUMOR BURDEN;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
|
|
EID: 84910005238
PISSN: None
EISSN: 13497006
Source Type: Journal
DOI: 10.1111/cas.12475 Document Type: Article |
|
Times cited : (74)
|
|
References (0)
|
